Invalidity dossier

US 11000682

Hemostasis valves and methods of use

Current assignee: Stryker Corp

Added 9/23/2026, 4:49:52 PM

At a glanceNo PTAB challengesNo litigation on file

Active provider: DeepSeek · deepseek-flash

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Patent Overview — US11000682B2

Title: Hemostasis valves and methods of use

Patent number: US11000682B2 | Application: US16/117,519 | Publication: US20190070401A1

Inventors: Benjamin E. Merritt, John C. Thress, Paul Lubock

Assignee: Inari Medical, Inc. (original and current assignee as listed)

Dates: Priority date 2017-09-06; filing date 2018-08-30; granted/publication date 2021-05-11. Google Patents lists legal status as active with adjusted expiration 2038-11-02.

Purpose: The patent addresses drawbacks of existing hemostasis valves used with catheters in minimally invasive surgery. Catheters are equipped with hemostasis valves that seal or selectably seal catheter lumens — both when a tool extends through the valve and when a tool is removed. The patent states some valves may not seal adequately for all interventional applications or tools, and some are complicated to operate, potentially increasing surgical complexity or reducing patient safety (e.g., bleeding, infection, other complications). It seeks new and improved hemostasis valves and methods of use.

Plain-language scope: The valve includes a tubular elongate member (described as a pliable, compliant polymer tube) with a first end, second end, and a central lumen. An active tensioning mechanism — including at least one filament extending at least partially around the elongate member — is coupled to the elongate member and is moveable between a first configuration (lumen constricted and sealed) and a second configuration (lumen open), with manual intermediate positions possible. A reinforcement structure (e.g., a braided mesh) extends along at least part of the elongate member, positioned between the filament and the elongate member, and is coupled near both ends but not between them in some embodiments. An actuator coupled to the filament controls filament movement; two tensioning mechanisms may operate in opposite directions. The stated benefit is sealing around a wide range of tool sizes and shapes, including multiple tools simultaneously, and maintaining a seal under vacuum aspiration.

Not established by this excerpt: The full claim set, dependent-claim details, exact embodiment figures, and the complete specification text are omitted; the excerpt therefore does not establish the precise legal scope of any claim. Litigation, ownership transfers, validity, and prior art were not examined.

Source: https://patents.google.com/patent/[US11000682](/patent/US11000682)/en

Generated 10/1/2026, 9:44:08 PM

Cases on file (0)

Specific litigation cases in our database that name US patent 11000682. The free-form analysis below may also discuss cases beyond this list.

No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Log in to generate
Not generated yet. Log in to request this analysis.

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Log in to generate
Not generated yet. Log in to request this analysis.

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Log in to generate
Not generated yet. Log in to request this analysis.

Prior art

Earlier patents, publications, and products that may anticipate or render the claims unpatentable.

Log in to generate
Not generated yet. Log in to request this analysis.

Obviousness

Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.

Log in to generate
Not generated yet. Log in to request this analysis.

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Log in to generate
Not generated yet. Log in to request this analysis.

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Log in to generate
Not generated yet. Log in to request this analysis.